한미FTA와 의약품 - pharmacist.or.kr

한미FTA와 의약품 - pharmacist.or.kr

FTA FTA FTA CONTENTS 1. 2. 14% 27% FTA 2006 5 3

1,2 8 . 16 16 -1 USTR - A7 - - - - 2 16 (1) , (2) , (3) , (4) , (5) , , (6) , (7)

(8) - 2 16 (9) , , , (10) , , , (11) , - , , , , - (12) (13) (14) (15) (16) / -1 16 FTA USTR WORKING GROUP 16 . .

-2 . 2002 FDA 87 70 ("me too" drug )me too"me too" drug ) drug ) . 17 7 ( 1. 2. ) 2004 Single-source 27.7% . 31.8% . 2001 (41,804 ) 4 2005 (72,289 ) 73% 60% 1. 1987, 1997, 2004 Report ) (Data from 2004 PMPRB Annual 2. 2005 6 , , . (%) (Data from http://www.nlarx.org/policy/pricedisclosure.html )

Percent Increase in U.S. Prescription Drug Prices for the Top Selling Drugs Versus the Average Price among Australia, Canada, Germany, and the United Kingdom, June 2005. 250 225 200 175 NOTE: Chart excludes the tw o drugs for w hich the U.S. price w as the low est and those for w hich pricing information is not available. Source: Med Ad New s, Special Report, "Top 500 Prescription Drugs"; w w w .cvs.com; w w w .drugstore.com; w w w .canadadrug.com; w w w .englandmeds.com; w w w .apotheke.de; w w w .emedical.com.au; w w w .homepharmacy.com.au 125 113 75 25 147 91 68 105

100 96 97 83 72 65 63 53 50 152 110 96 100 217 211 52 39 51 46 39

32 23 64 54 34 26 25 25 6 0 Li pi to r Zo co Ad r v N ai r or va Zy s c pr ex a N ex iu

m Zo lo Ef f t fe xo r Pl av C el i x eb Fo re x sa m a D x io R van is pe rd C al oz N aa eu r ro Pr nti av n ac ho Si ng l u

Pr l air ev a Lo ci d ve n Av ox an Se di a ro qu Pa el xi lC Zi th ro Al l R e m a x gra ZPa c Am k bi N en eu la st a Ac to Pr s ot on

Av ix on To ex pa To max W pro l-X el lb ut L ri n XL Percent 150 Denotes the point at w hich U.S. prices exceeds the average international price by over 30 percent -3 A7 A7 . . 2006 23,045 FSS 19,135 Big4 12,490 .( 1. ) . FTA

1. 2006 FSS, Big 4 ($1 = 952 ) FSS Big 4 2mg 885 1,514 1,247

2,113 200mg , , 980 2,122 1,675 3,065 100mg , 23,045 19,135 12,490 21,258

250 62,010 49,104 37,966 57,444 5mg 5,200 4,322 4,322 7,273

20mg 20,653 17,117 17,117 29,702 100mg 102,527 85,813 85,813 143,695 250mg

242,815 219,588 219,588 363,597 25mg 164,000 85,680 85,680 164,743 3.5mg

1,144,673 671,893 671,893 FSS Big 4 www.pbm.va.gov/pbm/prices.htm, www.drugstore.com - (same product) (similar products) .

FTA 2003 "me too" drug )same or similiar product"me too" drug ) Article 16.8:1 2003 "me too" drug )same product"me too" drug ) Article 17.10:1 FTA CAFTA-DR 2004 "me too" drug )same product"me too" drug ) Article 15.1 01(a) 2004 "me too" drug )same or similiar product"me too" drug ) Article 17,10:1 (a) 2004 "me too" drug )same product"me too" drug ) Article 15.10:1 2004 "me too" drug )same or similiar product"me too" drug ) Article 14.9:1 (a) 2006 "me too" drug )same or similiar product"me too" drug ) Article 15.9 : 1 (a) 2006 "me too" drug )same or similiar product"me too" drug ) Article 16.10 : 1 (a) - . .

3 . (i) , (ii) public non-commercial use( , (government use) ) , (iii) 2001 FTA Andean, FTAA, CAFTA, 4 . (trade representatives) 5

- 10 - - FTA - FTA FTA 9.7%, 10 100% 70-90 FTA 15 1 7 -1

0.9 0.8 0.7 1 25,361 4.5% 24,334.1

1,027.1 24,448.2 913.0 24,562.3 798.9 2 24,822 8.5% 22,922.7 1,898.9 23,133.7 1,687.9 23,344.7 1,476.9 3 24,282 9.7%

22,162.2 2,119.8 22,397.7 1,884.3 22,633.3 1,648.7 4 23,742 10.2% 21,562.8 2,179.6 21,805.0 1,937.4 22,047.2 1,695.2 5 23,203

10.5% 21,010.1 2,192.7 21,253.8 1,949.0 21,497.4 1,705.4 * : -2 0.9 0.8 0.7 1 1

1027.1 913.0 798.9 2 2 2926.0 2600.9 2275.8 3 3 5045.8 4485.2 3924.5 4 4 7225.4 6422.5

5619.7 5 5 9418.0 8371.6 7325.1 * : FTA FTA 2004 361 175 4

8% 2005 1 87 2 , 17 19 , 2 1 1989 1996 18 239 299 46% 2002 6 1 73% 56% 46% - FTA 21.2 64.3 2005 8

FTA .

Recently Viewed Presentations

  •  TIP: Use only this front page for simple

    TIP: Use only this front page for simple

    Opportunity or problem this idea will address & rationale. ... to track project performance, the best business cases define and monitor leading indicators to allow time for mid-course correction and improve project benefit realisation. ... Identify key stakeholders inside and...
  • Soil - Georgetown High School

    Soil - Georgetown High School

    Soil texture describes the size of the mineral particles that make up soil. The 3 main grain sizes are sand, silt, and clay. The 3 subcategories of soil are loam, peat, and chalk. Soil Profiles Soils are formed in layers...
  • The Evolution of Egyptian Pyramid Construction

    The Evolution of Egyptian Pyramid Construction

    Mastaba "House of eternity" Traced back to Pharaoh Aha (2686 BCE) Designed as protection for the mummy. Tombs carved into the bedrock and covered with mud bricks with enclosures on the sides
  • Antonyms - Effingham County School District

    Antonyms - Effingham County School District

    Antonyms By Sylvia Smith What are antonyms? Antonyms are words that have opposite meanings. Come Go Find the antonym to: Click on the correct answer and hear the clapping. hot mad cold sad Find the antonym to: dog rabbit bird...
  • Improving Writing Using Talk for Writing and Support for Writing

    Improving Writing Using Talk for Writing and Support for Writing

    The other main approach to teaching phonics is "analytic" phonics. Synthetic phonics starts by giving the children the GPCs and showing them how to blend them , or "synthesise" them, to make words. Of course, this means they have to...
  • Love, red blue By Robert Indiana Corridor pin,

    Love, red blue By Robert Indiana Corridor pin,

    Corridor pin, blue. By Coosje van Bruggen and Claes Oldenburg. Monkeys. By Rona Pondick. The Drummer. By Michael Sandle
  • CRITICAL THINKING AND EAP WRITING A meta-synthesis of

    CRITICAL THINKING AND EAP WRITING A meta-synthesis of

    The link between critical thinking & academic writing remains an area where research is somewhat limited, but the key concepts/skills that occur repeatedly include argument, making supported claims, developing voice/stance - this can be seen in the definition (taken from...
  • Leading Project Teams Virtually II -Maintaining Momentum For

    Leading Project Teams Virtually II -Maintaining Momentum For

    This is the HBDI - Herrmann Brain Dominance Instrument model, which comes from Ned Herrmann's 30 years of work on brain spheres (left/right - upper/lower) and the strengths of each. Using the model helps us describe the degree of preference...